Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Dermatol ; 30(5): 745-750, 2021 05.
Article in English | MEDLINE | ID: mdl-33403711

ABSTRACT

This study aimed to investigate the molecular effects of radiation and subsequent aftercare treatment with dexpanthenol-containing ointment and liquid on established full-thickness 3D skin models depicting acute radiodermatitis and mucositis. To mimic radiomucositis and radiodermatitis, non-keratinized mucous membrane and normal human skin models were irradiated with 5 Gray. Afterwards, models were treated topically every second day with dexpanthenol-containing ointment or liquid in comparison with placebo and untreated controls. On day 7 after irradiation, histological examination showed impairments in irradiated models. In contrast, models treated with dexpanthenol-containing ointment or liquid showed a completely restored epidermal part. While gene expression profiling revealed an induction of genes related to a pro-inflammatory milieu, oxidative stress and an impaired epidermal differentiation after irradiation of the models, aftercare treatment with dexpanthenol-containing ointment or liquid revealed anti-oxidative and anti-inflammatory effects and had a positive effect on epidermal differentiation and structures important for physical and antimicrobial barrier function. Our findings confirm the potential of our established models as in vitro tools for the replacement of pharmacological in vivo studies regarding radiation-induced skin injuries and give indications of the positive effects of dexpanthenol-containing externals after radiation treatments as part of supportive tumor treatment.


Subject(s)
Dermatologic Agents/therapeutic use , Keratinocytes/drug effects , Mouth Mucosa/radiation effects , Ointments/therapeutic use , Pantothenic Acid/analogs & derivatives , Administration, Topical , Aftercare , Epidermis/drug effects , Humans , Pantothenic Acid/therapeutic use , Wound Healing/drug effects
2.
PLoS One ; 11(11): e0166766, 2016.
Article in English | MEDLINE | ID: mdl-27902742

ABSTRACT

BACKGROUND: Treatment of nasopharyngeal carcinoma requires the application of high dosages of radiation, leading to severe long-term complications in the majority of patients. Sensitizing tumor cells to radiation could be a means to increase the therapeutic window of radiation. Nasopharyngeal carcinoma cells display alterations in autophagy and blockade of autophagy has been shown to sensitize them against chemotherapy. METHODS: We investigated the effect of chloroquine, a known inhibitor of autophagy, on sensitization against radiation-induced apoptosis in a panel of five nasopharyngeal carcinoma cell lines and a SV40-transformed nasoepithelial cell line. Autophagy was measured by immunoblot of autophagy-related proteins, immunofluorescence of autophagosomic microvesicles and electron microscopy. Autophagy was blocked by siRNA against autophagy-related proteins 3, 5, 6 and 7 (ATG3, ATG5, ATG6 and ATG7). RESULTS: Chloroquine sensitized four out of five nasopharyngeal cancer cell lines towards radiation-induced apoptosis. The sensitizing effect was based on the blockade of autophagy as inhibition of ATG3, ATG5, ATG6 and ATG7 by specific siRNA could substitute for the effect of chloroquine. No sensitization was seen in nasoepithelial cells. CONCLUSION: Chloroquine sensitizes nasopharyngeal carcinoma cells but not nasoepithelial cells towards radiation-induced apoptosis by blocking autophagy. Further studies in a mouse-xenograft model are warranted to substantiate this effect in vivo.


Subject(s)
Apoptosis/drug effects , Apoptosis/radiation effects , Autophagy/drug effects , Autophagy/genetics , Carcinoma/radiotherapy , Chloroquine/pharmacology , Epithelial Cells/radiation effects , Nasopharyngeal Neoplasms/radiotherapy , Radiation-Sensitizing Agents/pharmacology , Autophagy-Related Protein 5/genetics , Autophagy-Related Protein 7/genetics , Autophagy-Related Proteins/genetics , Beclin-1/genetics , Carcinoma/drug therapy , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Proliferation/radiation effects , Epithelial Cells/drug effects , Humans , In Situ Nick-End Labeling , Nasal Mucosa/cytology , Nasopharyngeal Carcinoma , Nasopharyngeal Neoplasms/drug therapy , RNA Interference , RNA, Small Interfering/genetics , Ubiquitin-Conjugating Enzymes/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...